DE | EN

Dr.med. Matthias Meyborg

Current affiliations

Klinik für Kardiologie I

Publications

Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis Pohl, Sarah B.; Engelbertz, Christiane; Reinecke, Holger; Malyar, Nasser M.; Meyborg, Matthias; Brix, Tobias J.; Varghese, Julian; Gebauer, Katrin (2024) In: Nutrition, Metabolism and Cardiovascular Diseases, 34(7) Type of Publication: Research article (journal)
Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence Mueller L; Engelbertz C; Reinecke H; Freisinger E; Malyar NM; Meyborg M; Brix TJ; Varghese J; Gebauer K (2022) In: Journal of Clinical Medicine, 11(22) Type of Publication: Research article (journal)
[Medication-based secondary prevention in patients with peripheral arterial occlusive disease : An analysis based on secondary data]. Gebauer, K; Wintersohl, K; Kraska, R; Kortendick, K; Fahrland, U; Freisinger, E; Meyborg, M; Stella, J; Engelbertz, C; Reinecke, H; Malyar, N (2021) In: Herz, 46(Suppl 2) Type of Publication: Research article (journal)
Access Site Related Vascular Complications following Percutaneous Cardiovascular Procedures. Hetrodt, Johanna; Engelbertz, Christiane; Gebauer, Katrin; Stella, Jacqueline; Meyborg, Matthias; Freisinger, Eva; Reinecke, Holger; Malyar, Nasser (2021) In: Journal of cardiovascular development and disease, 8(11) Type of Publication: Research article (journal)
Feasibility and impact of carbon dioxide angiography on acute kidney injury following endovascular interventions in patients with peripheral artery disease and renal impairment. Jakobi, Tim; Meyborg, Matthias; Freisinger, Eva; Gebauer, Katrin; Stella, Jacqueline; Engelbertz, Christiane; Reinecke, Holger; Malyar, Nasser M (2021) In: Journal of Nephrology, 34(3) Type of Publication: Research article (journal)

Show all publications

Projects

Single-arm, non-randomized, prospective, multi-center study with the Bard® LifeStent® Vascular Stent Delivery. (BARD) Duration: 01/08/2010 - 31/07/2013 Funded by: Bard Peripheral Vascular Inc. Type of project: Individual project
A randomized double-blind placebo-controlled parallel group study of the efficacy and safety of 4 administrations of XRP0038/NV1FGF 4mg at 2-week intervals on… (TAMARIS) Duration: 01/06/2008 - 31/05/2011 Funded by: sanofi-aventis Deutschland GmbH Type of project: Individual project